Cerebrolysin

This nootropic has no healthy human placebo-controlled studies that meet our inclusion criteria. Negative side effects can occur if used carelessly, so make sure you’re aware of the risks of Cerebrolysin.

Browser our suppliers for Cerebrolysin

Risks

The legality and side effects of Cerebrolysin

You should always consider the risks of a nootropic before you use it.

Side effects

Interactions

Supplements and drugs can interact with Cerebrolysin to increase or decrease the positive or negative effects you experience. If you are already using any supplements or drugs, speak with your trusted medical professional before you experiment with Cerebrolysin. To learn more about the potential interactions between Cerebrolysin and other substances, use interaction-checker.

Legality

Is your country not included? Learn how to find out if Cerebrolysin is legal in your country.

Legality Disclaimer

The contents herein are not legal advice or a substitute for legal counsel. information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. While we have done our best to be as accurate as possible in the information we convey to you about the legality of nootropics, there is a risk for inaccuracies and errors. If you’re uncertain about the legality of any of your actions, contact a legal counsel or your local authorities governing the legality of various substances you may want to use/import/travel with.

Studies

Studies conducted on the effects of Cerebrolysin in healthy humans

No placebo-controlled trials on healthy humans that meet our inclusion criteria have been conducted on Cerebrolysin.

Dose-dependent effects of Cerebrolysin on EEG and short-term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia

placebo-controlled

Summary

"For short term memory, there is a trend towards less effective word recall for the baseline situation during the first 4 hours for the placebo. This effect was not observed in the Cerebrolysin® treated groups."

Last updated Saturday, June 10, 2023